Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study.

Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP.

Eur Heart J. 2007 Sep;28(18):2249-55. Epub 2007 Jul 19.

PMID:
17644511
2.

Coenzyme Q10 and exercise training in chronic heart failure.

Belardinelli R, Muçaj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F, Tiano L, Littarru GP.

Eur Heart J. 2006 Nov;27(22):2675-81. Epub 2006 Aug 1.

PMID:
16882678
3.

The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia.

Halcox JP, Nour KR, Zalos G, Mincemoyer RA, Waclawiw M, Rivera CE, Willie G, Ellahham S, Quyyumi AA.

J Am Coll Cardiol. 2002 Oct 2;40(7):1232-40.

4.

Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.

Watts GF, Playford DA, Croft KD, Ward NC, Mori TA, Burke V.

Diabetologia. 2002 Mar;45(3):420-6.

PMID:
11914748
5.

Bioenergetic and antioxidant properties of coenzyme Q10: recent developments.

Littarru GP, Tiano L.

Mol Biotechnol. 2007 Sep;37(1):31-7. Review.

PMID:
17914161
6.

Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure.

Belardinelli R, Muçaj A, Lacalaprice F, Solenghi M, Principi F, Tiano L, Littarru GP.

Biofactors. 2005;25(1-4):137-45.

PMID:
16873938
7.

Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial.

Dai YL, Luk TH, Yiu KH, Wang M, Yip PM, Lee SW, Li SW, Tam S, Fong B, Lau CP, Siu CW, Tse HF.

Atherosclerosis. 2011 Jun;216(2):395-401. doi: 10.1016/j.atherosclerosis.2011.02.013. Epub 2011 Feb 17.

PMID:
21388622
8.

Oxidative stress, endothelial function and coenzyme Q10.

Belardinelli R, Tiano L, Littarru GP.

Biofactors. 2008;32(1-4):129-33.

PMID:
19096108
9.

Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.

Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.

Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):533-40. doi: 10.1097/HJR.0b013e328304feec.

PMID:
18797405
10.

Gene transfer of extracellular superoxide dismutase improves endothelial function in rats with heart failure.

Iida S, Chu Y, Francis J, Weiss RM, Gunnett CA, Faraci FM, Heistad DD.

Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H525-32.

11.

Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation.

Landmesser U, Merten R, Spiekermann S, Büttner K, Drexler H, Hornig B.

Circulation. 2000 May 16;101(19):2264-70.

12.

Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.

Hamilton SJ, Chew GT, Watts GF.

Diabetes Care. 2009 May;32(5):810-2. doi: 10.2337/dc08-1736. Epub 2009 Feb 19.

13.

Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.

Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Müller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H; German Coenzyme Q(10) Study Group.

Arch Neurol. 2007 Jul;64(7):938-44. Epub 2007 May 14.

PMID:
17502459
14.

Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice.

Jung O, Marklund SL, Geiger H, Pedrazzini T, Busse R, Brandes RP.

Circ Res. 2003 Oct 3;93(7):622-9. Epub 2003 Aug 21.

15.

Effect of an exercise training program on endothelial dysfunction in diabetic and non-diabetic patients with severe chronic heart failure.

Miche E, Herrmann G, Nowak M, Wirtz U, Tietz M, Hürst M, Zoller B, Radzewitz A.

Clin Res Cardiol. 2006 Jan;95 Suppl 1:i117-24.

PMID:
16598538
16.

Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease.

Lee BJ, Huang YC, Chen SJ, Lin PT.

Nutrition. 2012 Mar;28(3):250-5. doi: 10.1016/j.nut.2011.06.004. Epub 2011 Oct 12.

PMID:
21996047
17.
18.

Inactivation of extracellular superoxide dismutase contributes to the development of high-volume hypertension.

Jung O, Marklund SL, Xia N, Busse R, Brandes RP.

Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):470-7. Epub 2006 Dec 14.

19.

Molsidomine improves flow-dependent vasodilation in brachial arteries of patients with coronary artery disease.

Belhassen L, Carville C, Pelle G, Sediame S, Benacerraf S, Dubois-Randé JL, Adnot S.

J Cardiovasc Pharmacol. 2000 Apr;35(4):560-3.

PMID:
10774786
20.

Vascular effects of a common gene variant of extracellular superoxide dismutase in heart failure.

Iida S, Chu Y, Weiss RM, Kang YM, Faraci FM, Heistad DD.

Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H914-20.

Supplemental Content

Support Center